Skip to Main Content

Paper Details

A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine.
Front Immunol
18
2021
Author NameAffiliation
Raveen RathnasingheIcahn School of Medicine at Mount Sinai New York
Raveen RathnasingheGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Raveen RathnasingheIcahn School of Medicine at Mount Sinai
Michael SchotsaertIcahn School of Medicine at Mount Sinai New York
Michael SchotsaertGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 5

Datasets

Release 1.2